Authors:
Feldmann, M
Brennan, F
Bondeson, J
Paleolog, E
Foxwell, B
Maini, R
Citation: M. Feldmann et al., Analysis of cytokine expression in rheumatoid synovium has provided new insights into the pathogenesis of rheumatoid arthritis and new therapeutic opportunities, TRANSPLAN P, 33(3), 2001, pp. 2085-2086
Citation: Pc. Taylor et al., Similar effects of pulse corticosteroid and tumor necrosis factor a blockade in rheumatoid arthritis: Reply, ARTH RHEUM, 44(1), 2001, pp. 245-246
Authors:
Miotla, J
Maciewicz, R
Kendrew, J
Feldmann, M
Paleolog, E
Citation: J. Miotla et al., Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis, LAB INV, 80(8), 2000, pp. 1195-1205
Authors:
Taylor, PC
Peters, AM
Paleolog, E
Chapman, PT
Elliot, MJ
McCloskey, R
Feldmann, M
Maini, RN
Citation: Pc. Taylor et al., Reduction of chemokine levels and leukocyte traffic to joints by tumor necrosis factor alpha blockade in patients with rheumatoid arthritis, ARTH RHEUM, 43(1), 2000, pp. 38-47
Authors:
Maini, RN
Taylor, PC
Paleolog, E
Charles, P
Ballara, S
Brennan, FM
Feldmann, M
Citation: Rn. Maini et al., Anti-tumour necrosis factor specific antibody (infliximab) treatment provides insights into the pathophysiology of rheumatoid arthritis, ANN RHEUM D, 58, 1999, pp. 56-60
Authors:
Feldman, M
Taylor, P
Paleolog, E
Brennan, FM
Maini, RN
Citation: M. Feldman et al., Anti-TNF alpha therapy is useful in rheumatoid arthritis and Crohn's disease: Analysis of the mechanism of action predicts utility in other diseases, TRANSPLAN P, 30(8), 1998, pp. 4126-4127